Andrew L. Pecora, MD

When Andrew L. Pecora, M.D., FACP, CPE, joined John Theurer Cancer Center, he elevated cancer care to the department level and reorganized cancer services into 14 separate divisions. His accomplishments include the aggressive recruitment of leading oncologists from all over the United States, the addition of innovative basic research and clinical trials, the expansion of patient care services, and the acquisition of new state-of-the-art technology that has helped make John Theurer Cancer Center one of that nation’s top 50 best cancer centers — and the only one in New Jersey with this designation.

A certified hematologist/oncologist, Dr. Pecora is recognized internationally as one of the world’s foremost experts in blood and marrow stem cell transplantation, cellular medicine, and immunology research. In 1989, he spearheaded the development of John Theurer Cancer Center’s Adult Blood and Marrow Stem Cell Transplantation Program and is responsible for many advancements used in stem cell transplantation today. 

Dr. Pecora’s current research involves developing vaccines and other cellular therapies that boost the power of a patient’s own immune system to fight cancer, as well as targeted therapies that destroy cancer cells. His research has been published extensively in prestigious medical journals, and he is a frequently requested lecturer at conferences all over the world. Dr. Pecora’s award-winning research is funded by the National Cancer Institute, Amgen, Merck, and the AHEPA Research Foundation.